Drug Shortage Report for MYLAN-BUPROPION XL
Report ID | 3941 |
Drug Identification Number | 02382075 |
Brand name | MYLAN-BUPROPION XL |
Common or Proper name | BUPROPION XL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | BUPROPION HYDROCHLORIDE |
Strength(s) | 150MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 90BT, 500BT |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-05-18 |
Actual start date | 2018-05-04 |
Estimated end date | 2019-09-30 |
Actual end date | 2019-06-18 |
Shortage status | Resolved |
Updated date | 2019-06-19 |
Company comments | Manufacturing issues |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.